Mass Spectrometry

Then & Now, with Amadeo Fernández-Alba, Professor at the University of Almeria, Spain.

Tom Metz, Integrative Omics Scientist and Metabolomics Technical Lead at Pacific Northwest National Laboratory (Washington State, USA), selects six papers that exemplify the power of multi-omics.

From hardcore peptide biochemist to translational scientist, it’s been an unconventional journey for Jennifer Van Eyk, Director of the Advanced Clinical Biosystems Research Institute at Cedars-Sinai Medical Center, Los Angeles. Here, Jenny tells us what she’s learnt along the way.

Cancer is incredibly complex, posing enormous challenges beyond the biological field. Taking a multi-omic approach can help us make sense of this diverse set of diseases – and, ultimately, allow us to better understand ourselves as human beings.

Sitting Down With... Jessica Prenni, Director of Research Core Facilities, Director of Proteomics & Metabolomics Facility, Colorado State University, USA.

Detecting and controlling mutagenic impurities in pharmaceuticals is challenging. What is ICH M7 and what do you need in your analytical toolbox?

When disruptive technology comes along, it can be hard to defend the technique under attack for some applications – even if we have embraced it for decades.

What’s new in business this month?

Is a new and improved mass spectrometer the “Holy Grail” of chemical sensing?

Using PTR-MS to track the chemistry of group emotion